Concepedia

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices

Almea Matanock, Grace Lee, Ryan Gierke, Miwako Kobayashi, Andrew J. Leidner, Tamara Pilishvili

MMWR Morbidity and Mortality Weekly Report · 2019 · 337 citations · 22 references

DOIFull text

Open access

Concepts

Abstract

Recommendations for use of vaccines in children, adolescents, and adults are developed by the Advisory Committee on Immunization Practices (ACIP). ACIP is chartered as a federal advisory committee to provide expert

References

22

Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults

Marc J. M. Bonten, Susanne M. Huijts, Marieke Bolkenbaas et al. · New England Journal of Medicine · 2015 · 1.2K citations · Full text

, , +17

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults With Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

American Journal of Transplantation · 2012 · 690 citations · Full text

, , +14

Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23).

J. Pekka Nuorti, Cynthia G. Whitney · MMWR Morbidity and Mortality Weekly Report · 2010 · 373 citations

, , +17

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults With Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

JAMA · 2013 · 326 citations

, , +14

Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children - Advisory Committee on Immunization Practices (ACIP), 2010.

PubMed · 2010 · 259 citations

, , +17